TNF and hepatocellular carcinoma: The preliminary finding that the changes in MRI parameters are associated with the changes in circulating sVEGFR2 and TNF-α suggests that the rapid drop in vessel leakiness in HCC after sunitinib treatment may potentially occur by direct blockade of VEGF/VEGFR2 signaling or indirectly by reduction of TNF-α.